| Goodwill | 5,605a | 265a |
| Other intangible assets | 4,419.2a | 343a |
| Property, plant and equipment | 2,968.3a | 1,653.8a |
| Deferred tax assets | 275a | 236.4a |
| Other financial assets | 18.7a | 8.3a |
| Investments in associates | 24a | 27.5a |
| Other receivables | 6a | 5.9a |
| Non-current assets | 13,316.2a | 2,539.9a |
| Inventories | 720.6a | 486.7a |
| Trade receivables | 665.6a | 496.7a |
| Contract assets | 23.6a | 9.4a |
| Tax receivables | 58.6a | 39.7a |
| Other receivables | 115.4a | 37.4a |
| Other financial assets | 4a | 5.4a |
| Cash and cash equivalents | 280a | 149.7a |
| Assets held for sale | 11.6a | 44.5a |
| Current assets | 1,879.4a | 1,269.5a |
| Assets | 15,195.6a | 3,809.4a |
| Common shares | 125.6a | 75.4a |
| Reserves and retained earnings | 11,050.4a | 1,800.2a |
| Equity attributable to shareholders of Novozymes A/S | 11,176a | 1,875.6a |
| Non-controlling interests | | 50a |
| Total equity | 11,176a | 1,925.6a |
| Deferred tax liabilities | 1,255.9a | 263.6a |
| Provisions | 39.7a | 15.1a |
| Contract liabilities | 105.3a | 20.4a |
| Borrowings | 1,530.4a | 612a |
| Non-current liabilities | 2,931.3a | 911.1a |
| Share purchase liability | | 78.4a |
| Borrowings | 266.4a | 432a |
| Trade payables | 423.1a | 216.9a |
| Contract liabilities | 22.8a | 8.7a |
| Tax payables | 60.9a | 24.6a |
| Other liabilities | 315.1a | 212.1a |
| Current liabilities | 1,088.3a | 972.7a |
| Liabilities | 4,019.6a | 1,883.8a |
| Liabilities and equity | 15,195.6a | 3,809.4a |